Results 11 to 20 of about 47,170 (292)
Change Management in a Biopharmaceutical Company [PDF]
, 2020 Masters of ScienceThis study aimed to review the change management implemented in a Biopharmaceutical company in Cape Town in the light of existing literature on change management theory.
Terblanche, Thersia
core +3 more sources
Immunogenicity of biopharmaceuticals [PDF]
Nephrology Dialysis Transplantation, 2006 The availability of biopharmaceuticals has been increasing over the past decade and as their patents expire, the emergence of biosimilar agents approaches. The primary issue of concern for the safety of these agents is the potential for immunogenicity.
Michele, Kessler +2 more
openaire +2 more sources
The biopharmaceutical anomaly [PDF]
Nature Biotechnology, 2020 Investment and funding has continued to flow into biotech, unlike most business sectors. But with healthcare and hospital budgets increasingly under pressure, do belt-tightening and consolidation lie ahead? Melanie Senior investigates, with additional reporting by Riku Lahteenmaki.
openaire +2 more sources
Hybrid modeling for biopharmaceutical processes: advantages, opportunities, and implementation
Frontiers in Chemical Engineering, 2023 Process models are mathematical formulations (essentially a set of equations) that try to represent the real system/process in a digital or virtual form.
Harini Narayanan +5 more
doaj +1 more source
Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran [PDF]
Pharmaceutical Sciences, 2021 Background: Supply chain risk management can help companies detect potential hazards,mitigate potential risks, and thereby increase supply chain efficiency. The biopharmaceuticalindustry in Iran has a generic-based pharmerging market.
Hadi Abbasian +6 more
doaj +1 more source
Considerations for applying bioethics norms to a biopharmaceutical industry setting
, 2021 Background: The biopharmaceutical industry operates at the intersection of life sciences, clinical research, clinical care, public health, and business, which presents distinct operational and ethical challenges.
Poplazarova, Tatjana +4 more
core +1 more source
Biotechnology Journal, 2006 AbstractThe biopharmaceutical industry, whose products are produced mainly by recombinant DNA technology, antibody technologies and cytotechnology, is the most important sector in industrial biotechnology, and is one of the most rapidly growing high‐tech industries.
Xianwen, Hu, Qingjun, Ma, Shuyong, Zhang
openaire +3 more sources
The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
Antibodies, 2019 The usefulness of higher-order structural information provided by hydrogen/deuterium exchange-mass spectrometry (H/DX-MS) for the structural impact analyses of chemical and post-translational antibody modifications has been demonstrated in various ...
Felix Kuhne +9 more
doaj +1 more source
Separations, 2018 Antibody-drug conjugates (ADCs) are promising state-of-the-art biopharmaceutical drugs for selective drug-delivery applications and the treatment of diseases such as cancer.
Filip S. Ekholm +8 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2020 “Values-based decision-making” frameworks and models are widely described in the literature in various disciplines, including healthcare settings.
Tatjana Poplazarova +2 more
doaj +1 more source